Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 The increasing prevalence of sciatica globally
3.2.1.2 Advancements in medical imaging and diagnostics
3.2.1.3 Rising awareness and demand for treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complications associated with sciatic surgery
3.2.2.2 High costs associated with research and development
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Acute
5.3 Chronic
Chapter 6 Market Estimates and Forecast, By Drug Class, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Steroids
6.3 Antidepressants
6.4 Corticosteroids
6.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
6.6 Other drug classes
Chapter 7 Market Estimates and Forecast, By By Distribution Channel, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Online pharmacies
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Amneal Pharmaceuticals LLC.
9.3 Bayer AG
9.4 Bristol Myers Squibb
9.5 Eliem Therapeutics
9.6 Novartis AG
9.7 Pfizer Inc.
9.8 Scilex Holding
9.9 Sinfonia Biotherapeutics
9.10 Sorrento Therapeutics.
